The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer

A Mayer, M Takimoto, E Fritz, G Schellander, K Kofler… - Cancer, 1993 - Wiley Online Library
Background. Proliferating cell nuclear antigen (PCNA), a proliferation marker, epidermal
growth factor receptor (EGFR), a glycoprotein that plays a role in tumorigenesis by binding …

[HTML][HTML] First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE …

HS Wasan, P Gibbs, NK Sharma, J Taieb… - The Lancet …, 2017 - thelancet.com
Background Data suggest selective internal radiotherapy (SIRT) in third-line or subsequent
therapy for metastatic colorectal cancer has clinical benefit in patients with colorectal liver …

[HTML][HTML] Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): long-term results of a multicentre …

JA Bridgewater, SA Pugh, T Maishman… - The lancet …, 2020 - thelancet.com
Background The interim analysis of the multicentre New EPOC trial in patients with
resectable colorectal liver metastasis showed a significant reduction in progression-free …

Engineering antibodies for clinical applications in cancer

K Chester, B Pedley, B Tolner, J Violet, A Mayer… - Tumor Biology, 2004 - karger.com
The 'magic bullet'concept predicted over a century ago that antibodies would be used to
target cancer therapy. Since then initial problems that were related to specificity, purity and …

Errors and discrepancies in the administration of intravenous infusions: a mixed methods multihospital observational study

I Lyons, D Furniss, A Blandford… - BMJ quality & …, 2018 - qualitysafety.bmj.com
Introduction Intravenous medication administration has traditionally been regarded as error
prone, with high potential for harm. A recent US multisite study revealed few potentially …

Recombinant anti-carcinoembryonic antigen antibodies for targeting cancer

KA Chester, A Mayer, J Bhatia, L Robson… - Cancer chemotherapy …, 2000 - Springer
Antibodies can be used to target cancer therapies to malignant tissue; the approach is
attractive because conventional treatments such as chemo-and radiotherapy are dose …

[HTML][HTML] Patients' and carers' experiences of interacting with home haemodialysis technology: implications for quality and safety

A Rajkomar, K Farrington, A Mayer, D Walker… - BMC nephrology, 2014 - Springer
Background Little is known about patients' and carers' experiences of interacting with home
haemodialysis (HHD) technology, in terms of user experience, how the design of the …

A Phase I study of single administration of antibody-directed enzyme prodrug therapy with the recombinant anti–carcinoembryonic antigen antibody-enzyme fusion …

A Mayer, RJ Francis, SK Sharma, B Tolner… - Clinical Cancer …, 2006 - AACR
Purpose: Antibody-directed enzyme prodrug therapy is a two-stage treatment whereby a
tumor-targeted antibody-enzyme complex localizes in tumor for selective conversion of …

Radioimmunoguided surgery in colorectal cancer using a genetically engineered anti-CEA single-chain Fv antibody

A Mayer, E Tsiompanou, D O'Malley, GM Boxer… - Clinical Cancer …, 2000 - AACR
In radioimmunoguided surgery (RIGS), a radiolabeled antibody is given iv before surgery
and a hand-held gamma-detecting probe is used to locate tumor in the operative field. The …

[HTML][HTML] Exploring medical device design and use through layers of distributed cognition: how a glucometer is coupled with its context

D Furniss, P Masci, P Curzon, A Mayer… - Journal of biomedical …, 2015 - Elsevier
Medical devices are becoming more interconnected and complex, and are increasingly
supported by fragmented organizational systems, eg through different processes …